These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 23888941)
1. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features. Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941 [TBL] [Abstract][Full Text] [Related]
2. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features. Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644 [TBL] [Abstract][Full Text] [Related]
3. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer. Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer. Cao Q; Lu K; Dai S; Hu Y; Fan W Int J Clin Exp Pathol; 2014; 7(5):2392-401. PubMed ID: 24966949 [TBL] [Abstract][Full Text] [Related]
5. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations. Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer. Cao Y; Shi H; Ren F; Jia Y; Zhang R Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer. Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577 [TBL] [Abstract][Full Text] [Related]
8. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6. Xia B; Yang S; Liu T; Lou G Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927 [TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. Peng DX; Luo M; Qiu LW; He YL; Wang XF Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341 [TBL] [Abstract][Full Text] [Related]
10. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression. Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788 [TBL] [Abstract][Full Text] [Related]
11. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4. Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer. Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832 [TBL] [Abstract][Full Text] [Related]
13. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer. Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508 [TBL] [Abstract][Full Text] [Related]
14. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer. Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1. Xu L; Li H; Su L; Lu Q; Liu Z Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517 [TBL] [Abstract][Full Text] [Related]
16. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852 [TBL] [Abstract][Full Text] [Related]
17. High Expression of MicroRNA-200a/b Indicates Potential Diagnostic and Prognostic Biomarkers in Epithelial Ovarian Cancer. Zhang B; Li Y; Li Y; Zhao H; An R Dis Markers; 2022; 2022():2751696. PubMed ID: 35371343 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑320 targets mitogen‑activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer. Xu Y; Hu J; Zhang C; Liu Y Mol Med Rep; 2017 Dec; 16(6):8530-8536. PubMed ID: 28990044 [TBL] [Abstract][Full Text] [Related]
19. Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer. Zuberi M; Khan I; Mir R; Gandhi G; Ray PC; Saxena A PLoS One; 2016; 11(4):e0153902. PubMed ID: 27092777 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer. Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]